Intellia Therapeutics: Top Speculative Trade In The Biotech Space

Bashar Issa
6.28K Followers

Summary

  • NTLA offers investors a unique opportunity to buy into an up-and-coming biotech company with impressive clinical data and the potential for future growth.
  • Management continues executing their plan to respond to the confluence of events that alienated shareholders and pushed down valuations.
  • With a beta of 2, NTLA offers an excellent opportunity for those seeking to capitalize on a potential market rebound.

Medical technicians Doctor looking at the microscope

toondelamour

Investment Thesis

Every industry, except for the energy sector, saw a market decline this year. There is no magic bullet to navigating the current climate, and your risk tolerance should guide your decision on what to trade. The two-year treasury yield offers a 4.3% annual

This article was written by

6.28K Followers
Bashar is a contributing writer at Seeking Alpha, focusing on Long/Short investment ideas, with a geographic focus in North America. Before that, Bashar worked at an Investment Fund in the United Kingdom. He has a Master's degree in Finance from the Queen Mary University of London and a Bachelor's degree in Economics from Middlesex University.

Analyst’s Disclosure:I/we have a beneficial long position in the shares of NTLA either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

About NTLA Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on NTLA

Related Stocks

SymbolLast Price% Chg
NTLA
--